Label: NICORETTE- nicotine polacrilex lozenge

  • NDC Code(s): 0135-0510-01, 0135-0510-06, 0135-0510-07, 0135-0511-01, view more
    0135-0511-06, 0135-0511-07
  • Packager: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Drug Application

Drug Label Information

Updated November 1, 2023

If you are a consumer or patient please visit this version.

  • Active ingredient (in each lozenge) (2 mg)

    Nicotine polacrilex, 2 mg

  • Active ingredient (in each lozenge) (4 mg)

    Nicotine polacrilex, 4 mg

  • Purpose

    Stop smoking aid

  • Use

    • reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking
  • Warnings

    If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider.

    Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.

    Do not use (Mint)

    • if you are allergic to soya

    Ask a doctor before use if you have

    • a sodium-restricted diet
    • heart disease, recent heart attack, or irregular heartbeat. Nicotine can increase your heart rate.
    • high blood pressure not controlled with medication. Nicotine can increase your blood pressure.
    • stomach ulcer or diabetes
    • history of seizures

    Ask a doctor or pharmacist before use if you are

    • using a non-nicotine stop smoking drug
    • taking prescription medicine for depression or asthma. Your prescription dose may need to be adjusted.

    Stop use and ask a doctor if

    • mouth problems occur
    • persistent indigestion or severe sore throat occurs
    • irregular heartbeat or palpitations occur
    • you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, diarrhea, weakness and rapid heartbeat
    • you have symptoms of an allergic reaction (such as difficulty breathing or rash)

    Keep out of reach of children and pets.

    Nicotine lozenges may have enough nicotine to make children and pets sick. If you need to remove the lozenge, wrap it in paper and throw away in the trash. In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions (2 mg)

    • if you are under 18 years of age, ask a doctor before use. No studies have been done to show if this product will work for you.
    • before using this product, read the enclosed User’s Guide for complete directions and other important information
    • begin using the lozenge on your quit day
    • if you smoke your first cigarette within 30 minutes of waking up,use 4 mg nicotine lozenge
    • if you smoke your first cigarette more than 30 minutes after waking up,use 2 mg nicotine lozenge according to the following 12 week schedule:

    Weeks 1 to 6

    Weeks 7 to 9

    Weeks 10 to 12

    1 lozenge every 1 to 2 hours

    1 lozenge every 2 to 4 hours

    1 lozenge every 4 to 8 hours

    • nicotine lozenge is a medicine and must be used a certain way to get the best results
    • place the lozenge in your mouth and allow the lozenge to slowly dissolve (about 20 - 30 minutes). Minimize swallowing. Do not chew or swallow lozenge.
    • you may feel a warm or tingling sensation
    • occasionally move the lozenge from one side of your mouth to the other until completely dissolved (about 20 - 30 minutes)
    • do not eat or drink 15 minutes before using or while the lozenge is in your mouth
    • to improve your chances of quitting, use at least 9 lozenges per day for the first 6 weeks
    • do not use more than one lozenge at a time or continuously use one lozenge after another since this may cause you hiccups, heartburn, nausea or other side effects
    • do not use more than 5 lozenges in 6 hours. Do not use more than 20 lozenges per day.
    • it is important to complete treatment. If you feel you need to use the lozenge for a longer period to keep from smoking, talk to your health care provider.
  • Directions (4 mg)

    • if you are under 18 years of age, ask a doctor before use. No studies have been done to show if this product will work for you.
    • before using this product, read the enclosed User’s Guide for complete directions and other important information
    • begin using the lozenge on your quit day
    • if you smoke your first cigarette more than 30 minutes after waking up,use 2 mg nicotine lozenge
    • if you smoke your first cigarette within 30 minutes of waking up,use 4 mg nicotine lozenge according to the following 12 week schedule:

    Weeks 1 to 6

    Weeks 7 to 9

    Weeks 10 to 12

    1 lozenge every 1 to 2 hours

    1 lozenge every 2 to 4 hours

    1 lozenge every 4 to 8 hours

    • nicotine lozenge is a medicine and must be used a certain way to get the best results
    • place the lozenge in your mouth and allow the lozenge to slowly dissolve (about 20 - 30 minutes). Minimize swallowing. Do not chew or swallow lozenge.
    • you may feel a warm or tingling sensation
    • occasionally move the lozenge from one side of your mouth to the other until completely dissolved (about 20 - 30 minutes)
    • do not eat or drink 15 minutes before using or while the lozenge is in your mouth
    • to improve your chances of quitting, use at least 9 lozenges per day for the first 6 weeks
    • do not use more than one lozenge at a time or continuously use one lozenge after another since this may cause you hiccups, heartburn, nausea or other side effects
    • do not use more than 5 lozenges in 6 hours. Do not use more than 20 lozenges per day.
    • it is important to complete treatment. If you feel you need to use the lozenge for a longer period to keep from smoking, talk to your health care provider.
  • Other information

    • each lozenge contains:sodium, 18 mg
    • Phenylketonurics: Contains Phenylalanine 3.4 mg per lozenge
    • store at 20 - 25°C (68 - 77°F)
    • keep POPPAC tightly closed and protect from light
  • Inactive ingredients

    acacia, aspartame, calcium polycarbophil, corn syrup solids, flavors, lactose, magnesium stearate, maltodextrin, mannitol, potassium bicarbonate, sodium alginate, sodium carbonate, soy protein, triethyl citrate, xanthan gum

  • Questions or comments?

    call toll-free 1-888-569-1743

  • Principal Display Panel

    NDC 0135-0510-07

    Nicorette ®

    nicotine polacrilex lozenge, 2 mg

    stop smoking aid

    Lozenge

    Includes User’s Guide

    2mg

    FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE MORE THAN 30 MINUTES AFTER WAKING UP.If you smoke your first cigarette WITHIN30 MINUTES of waking up, use Nicorette 4 mg Lozenge

    Mint

    144 Lozenges,2 mg Each

    (6 POPPAC ®Containers of 24)

    • not for sale to those under 18 years of age
    • proof of age required
    • not for sale in vending machines or from any source where proof of age cannot be verified

    TAMPER EVIDENT FEATURE:Do not use if clear neckband printed “SEALED FOR SAFETY” is missing or broken.

    Retain outer carton for full product uses, directions and warnings.

    TO INCREASE YOUR SUCCESS IN QUITTING:

    1. You must be motivated to quit.
    2. Use Enough -Use at least 9 Nicorette ®Lozenges per day during the first six weeks.
    3. Use Long Enough -Use Nicorette ®Lozenges for the full 12 weeks.
    4. Use With a Support Programas directed in the enclosed User’s Guide.

    Nicorette ®POPPAC ®

    To open vial, push in child resistant band on the POPPAC ®container with thumb.

    Flip up the top of the POPPAC ®and remove lozenge. A small amount of powder on opening of the POPPAC ®is normal.

    For more information and for a FREE individualized stop smoking program, please visit www.Nicorette.comor see inside for more details.

    Trademarks are owned by or licensed to the GSK group of companies.

    Distributed By:

    GSKConsumer Healthcare

    Warren, NJ 07059

    Made in Switzerland

    Made in the Switzerland

    ©2015 GSK group of companies or its licensor. All rights reserved.

    104959XC

    Nicorette Lozenge Mint 2mg 144 count carton
  • Principal Display Panel

    NDC 0135-0511-07

    Nicorette ®

    nicotine polacrilex lozenge, 4 mg

    stop smoking aid

    Lozenge

    Includes User’s Guide

    4 mg

    FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE WITHIN 30 MINUTES OF WAKING UP.

    If you smoke your first cigarette MORE THAN30 MINUTES after waking up, use Nicorette® 2 mg Lozenge

    Mint

    144 Lozenges,4 mg Each

    (6 POPPAC ®Containers of 24)

    • not for sale to those under 18 years of age
    • proof of age required
    • not for sale in vending machines or from any source where proof of age cannot be verified

    TAMPER EVIDENT FEATURE:Do not use if clear neckband printed “SEALED FOR SAFETY” is missing or broken.

    Retain outer carton for full product uses, directions and warnings.

    TO INCREASE YOUR SUCCESS IN QUITTING:

    1. You must be motivated to quit.
    2. Use Enough -Use at least 9 Nicorette ®Lozenges per day during the first six weeks.
    3. Use Long Enough -Use Nicorette ®for the full 12 weeks.
    4. Use With a Support Programas directed in the enclosed User’s Guide.

    Nicorette ®POPPAC ®

    To open vial, push in child resistant band on the POPPAC ®container with thumb.

    Flip up the top of the POPPAC ®and remove lozenge. A small amount of powder on opening of the POPPAC ®is normal.

    For more information and for a FREE individualized stop smoking program, please visit www.Nicorette.comor see inside for more details.

    Trademarks are owned by or licensed to the GSK group of companies.

    Distributed By:

    GSKConsumer Healthcare

    Warren, NJ 07059

    Made in the Switzerland

    ©2015 GSK group of companies or its licensor. All rights reserved.

    104960XC

    Nicorette Lozenge Mint 4mg 144 count carton
  • INGREDIENTS AND APPEARANCE
    NICORETTE 
    nicotine polacrilex lozenge
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0135-0510
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NICOTINE (UNII: 6M3C89ZY6R) (NICOTINE - UNII:6M3C89ZY6R) NICOTINE2 mg
    Inactive Ingredients
    Ingredient NameStrength
    POLACRILIN (UNII: RCZ785HI7S)  
    ACACIA (UNII: 5C5403N26O)  
    ASPARTAME (UNII: Z0H242BBR1)  
    CALCIUM POLYCARBOPHIL (UNII: 8F049NKY49)  
    CORN SYRUP (UNII: 9G5L16BK6N)  
    LACTOSE, UNSPECIFIED FORM (UNII: J2B2A4N98G)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    MANNITOL (UNII: 3OWL53L36A)  
    POTASSIUM BICARBONATE (UNII: HM5Z15LEBN)  
    SODIUM ALGINATE (UNII: C269C4G2ZQ)  
    SODIUM CARBONATE (UNII: 45P3261C7T)  
    SOY PROTEIN (UNII: R44IWB3RN5)  
    TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    Product Characteristics
    Colorwhite (white to off-white) Scoreno score
    ShapeROUNDSize16mm
    FlavorMINTImprint Code NL2S
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0135-0510-013 in 1 CARTON10/19/2010
    124 in 1 CONTAINER; Type 0: Not a Combination Product
    2NDC:0135-0510-061 in 1 CARTON09/01/2015
    224 in 1 CONTAINER; Type 0: Not a Combination Product
    3NDC:0135-0510-076 in 1 CARTON09/01/2015
    324 in 1 CONTAINER; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NDANDA02133010/19/2010
    NICORETTE 
    nicotine polacrilex lozenge
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0135-0511
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NICOTINE (UNII: 6M3C89ZY6R) (NICOTINE - UNII:6M3C89ZY6R) NICOTINE4 mg
    Inactive Ingredients
    Ingredient NameStrength
    POLACRILIN (UNII: RCZ785HI7S)  
    ACACIA (UNII: 5C5403N26O)  
    ASPARTAME (UNII: Z0H242BBR1)  
    CALCIUM POLYCARBOPHIL (UNII: 8F049NKY49)  
    CORN SYRUP (UNII: 9G5L16BK6N)  
    LACTOSE, UNSPECIFIED FORM (UNII: J2B2A4N98G)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    MANNITOL (UNII: 3OWL53L36A)  
    POTASSIUM BICARBONATE (UNII: HM5Z15LEBN)  
    SODIUM ALGINATE (UNII: C269C4G2ZQ)  
    SODIUM CARBONATE (UNII: 45P3261C7T)  
    SOY PROTEIN (UNII: R44IWB3RN5)  
    TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    Product Characteristics
    Colorwhite (white to off-white) Scoreno score
    ShapeROUNDSize16mm
    FlavorMINTImprint Code NL4S
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0135-0511-013 in 1 CARTON10/19/2010
    124 in 1 CONTAINER; Type 0: Not a Combination Product
    2NDC:0135-0511-061 in 1 CARTON09/01/2015
    224 in 1 CONTAINER; Type 0: Not a Combination Product
    3NDC:0135-0511-076 in 1 CARTON09/01/2015
    324 in 1 CONTAINER; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NDANDA02133010/19/2010
    Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263)